Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB: Safety Overview

Metric CARVEDILOL CASIRIVIMAB\IMDEVIMAB
Total FAERS Reports 13,678 4,248
Deaths Reported 2,246 137
Death Rate 16.4% 3.2%
Hospitalizations 6,005 1,351
Average Patient Age 63.9 yrs 54.3 yrs
% Female Patients 45.9% 55.4%
FDA Approval Date Dec 22, 2009 N/A
Manufacturer NorthStar RxLLC N/A
Route ORAL N/A
Marketing Status Prescription N/A